The SBC Catalyser Programme
Do you have a winning commercialisation strategy?
2025 PROGRAMME:
Dates will be confirmed in Autumn/Winter 2024
The Catalyser programme helps companies innovating in human health refine their commercialisation strategy
through a journey involving the analysis of 9 meso-economic vectors from the Triple Chasm framework
From the programme, the selected companies will gain:
- a refined commercialisation strategy
- a clear execution plan
- access to experts, potential partners and investors
The 6 highly-interactive sessions cover the strategy vectors:
- Market Space Definition
- Proposition Framing + Customer Definition
- Tech Management + IP Management
- Product Synthesis + Human Capital
- Funding Strategy + Strategic Positioning
- Final Presentations and Feedback
Each session includes:
- review of each startup strategy on previous vector
- presentation of Triple Chasm framework for the current vector
- introduction to Triple Chasm tools to help project the theory onto each startup case
- panel discussion with 3 industry experts to help understand real world scenarios and trend
Why you should apply
The SBC Catalyser programme provides:
- A comprehensive commercial strategy to go from idea to prototype
- A clear execution plan to translate the strategy into action
- Free virtual tenancy at SBC for 12 months, including access to the SBC events and a community including GSK, the Cell and Gene Therapy Catapult (CGTC) and over 40+ life sciences companies
- Free labspace and access to specialised equipment for 6 months awarded to best performing teams
- A strategically aware leadership team, able to evolve their commercialisation strategies in response to changes in markets and technologies
- An enhanced company profile
- Improved chances of getting the right funding at the right time
How to achieve your goals
The programme includes:
- 6 highly-interactive sessions to cover 8 strategy vectors
- A set of 25 strategy-profiling tools to design your path to success
- 5 panel discussions featuring 15+ industry leaders
- Access to the SBC community, including a world class team of mentors and experts, investors and partners
Who you are
- You are developing innovations for the benefit of human health
- You are en route to building a first proof of concept
- You have integrated digital and data technologies (ie ML/AI) in your R&D workflow, or you are planning to integrate them
- You have an existing presence in the UK, or you are planning to establish a presence in the UK
- You have an ambitious leadership team of at least 2-3 that can commit to full participation in the programme
Who we are
- Campus of 45+ therapeutics companies and largest cluster of CGT companies in Europe
- Companies based at SBC have raised more than £3.6bn since SBC’s birth in 2012, including 8 exits
- Our campus also includes GSK, LifeArc, CGTC and Cytiva
- We provide lab space, office space and business development support to our occupiers
- Our Lab Hotel provides free lab-space for 6 months to 7 selected early-stage companies
Read our Economic Impact Assessment report for more information.
Delivered in Collaboration with:
Why you should apply
The SBC Catalyser programme provides:
- A comprehensive commercial strategy to go from idea to prototype
- A clear execution plan to translate the strategy into action
- Free virtual occupancy at SBC for 12 months, including access to the SBC events and a community including GSK, the Cell and Gene Therapy Catapult (CGTC) and over 45+ life sciences companies
- Free lab space and access to specialised equipment for 6 months awarded to best performing teams
- A strategically aware leadership team, able to evolve their commercialisation strategies in response to changes in markets and technologies
- An enhanced company profile
- Improved chances of getting the right funding at the right time
How to achieve your goals
The programme includes:
- 6 highly-interactive sessions to cover 8 strategy vectors
- A set of 25 strategy-profiling tools to design your path to success
- 5 panel discussions featuring 15+ industry leaders
- Access to the SBC community, including a world class team of mentors and experts, investors and partners
Who you are
- You are developing innovations for the benefit of human health
- You are en route to building a first proof of concept
- You have integrated digital and data technologies (ie ML/AI) in your R&D workflow, or you are planning to integrate them
- You have an existing presence in the UK, or you are planning to establish a presence in the UK
- You have an ambitious leadership team of at least 2-3 that can commit to full participation in the programme
Who we are
- Campus of 45+ therapeutics companies and largest cluster of CGT companies in Europe
- Companies based at SBC have raised more than £3.6bn since SBC’s birth in 2012, including 8 exits
- Our campus also includes GSK, LifeArc, CGTC and Cytiva
- We provide lab-space, office-space and business development support to our occupiers
- Our Lab Hotel provides free lab-space for 6 months to 7 selected early-stage companies
Read our Economic Impact Assessment report for more information.
Delivered in Collaboration with:
Alumni
Find out about our Catalyser cohort members from 2023 and 2024 here.
